ArticleJournal of neuro-oncology2025
Multimodal pathomics and clinical features predict postresection permanent hydrocephalus in pediatric medulloblastoma.
Article in Journal of neuro-oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Multimodal integration of pathomics and clinical features improves recurrence risk prediction in pediatric medulloblastoma.Pediatric research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
purposePredicting postoperative persistent hydrocephalus risk in pediatric medulloblastoma remains challenging using conventional clinical features. We investigated whether deep learning (DL) of pathomic features could improve postoperative hydrocephalus risk stratification.
methodsWe analyzed patients under 18 years old with medulloblastoma treated at Zhujiang Hospital from January 2015 to September 2024, randomly split 7:3 into training and validation sets. Using ResNet-18 model, we extracted quantitative histopathological features from H&E-stained slides. We developed three logistic regression models to predict postoperative persistent hydrocephalus: (1) clinical model, (2) pathomic model, and (3) multimodal model (clinical + pathomics features). Model performance was evaluated using ROC and precision-recall curves. Risk group stratification was assessed with Kaplan-Meier plots and log-rank tests.
resultsA total of 90 patients was included in the study, 26(28.8%) patients required CSF diversion due to permanent hydrocephalus following tumor resection. On the validation set, the multimodal model achieved the highest predictive performance with an AUC of 0.849 (95% CI: 0.622-1.000) and average precision of 0.816 (95% CI: 0.535-1.000). The multimodal model improved risk-group stratification (3-year hydrocephalus-free survival for predicted high-risk: 37.7% versus low-risk: 89.5%, P < 0.001).
conclusionIntegrating deep learning-derived pathomic features with clinical variables significantly improves postoperative hydrocephalus risk stratification in pediatric medulloblastoma patients, facilitating personalized management strategies and ultimately enhancing patient outcomes.
Indexed as
Identifiers
41171470What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.